Blood-brain barrier (BBB) disruption is increasingly recognized as an early contributor to the pathophysiology of cerebral ischemia/reperfusion (I/R) injury, and is also a key event in triggering secondary damage to the central nervous system. Recently, long non-coding RNA (lncRNA) have been found to be associated with ischemic stroke. However, the roles of lncRNA in BBB homeostasis remain largely unknown. Here, we report that long intergenic non-coding RNA-p21 (lincRNA-p21) was the most significantly down-regulated lncRNA in human brain microvascular endothelial cells (HBMECs) after oxygen and glucose deprivation/reoxygenation (OGD/R) treatment among candidate lncRNA, which were both sensitive to hypoxia and involved in atherosclerosis. Exogenous brain-endothelium-specific overexpression of lincRNA-p21 could alleviate BBB disruption, diminish infarction volume and attenuate motor function deficits in middle cerebral artery occlusion/reperfusion (MCAO/R) mice. Further results showed that lincRNA-p21 was critical to maintain BBB integrity by inhibiting the degradation of junction proteins under MCAO/R and OGD/R conditions. Specifically, lincRNA-p21 could inhibit autophagy-dependent degradation of occludin by activating PI3K/AKT/mTOR signaling pathway. Besides, lincRNA-p21 could inhibit VE-cadherin degradation by binding with miR-101-3p. Together, we identify that lincRNA-p21 is critical for BBB integrity maintenance, and endothelial lincRNA-p21 overexpression could alleviate cerebral I/R injury in mice, pointing to a potential strategy to treat cerebral I/R injury.
BavarsadKBarretoGEHadjzadehMA, et al.
Protective effects of curcumin against Ischemia-Reperfusion injury in the nervous system. Mol Neurobiol2019;
56: 1391–1404.
2.
QinXWangJChenS, et al.
Astrocytic p75(NTR) expression provoked by ischemic stroke exacerbates the blood-brain barrier disruption. Glia2022;
70: 892–912.
3.
KnowlandDAracASekiguchiKJ, et al.
Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron2014;
82: 603–617.
4.
LangenUHAylooSGuC.Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol2019;
35: 591–613.
5.
KorteNIlkanZPearsonCL, et al.
The Ca2+-gated channel TMEM16A amplifies capillary pericyte contraction and reduces cerebral blood flow after ischemia. J Clin Invest2022;
132: e154118.
6.
NanDJinHDengJ, et al.
Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress. FASEB J2019;
33: 10152–10164.
7.
KimKAKimDKimJH, et al.
Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models. Fluids Barriers CNS2020;
17: 21.
8.
TakenagaYTakagiNMurotomiK, et al.
Inhibition of src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J Cereb Blood Flow Metab2009;
29: 1099–1108.
9.
HaarmannAZimmermannLBieberM, et al.
Regulation and release of vasoactive endoglin by brain endothelium in response to hypoxia/reoxygenation in stroke. Int J Mol Sci2022;
23: 7085.
10.
ZhangXTangXLiuK, et al.
Long noncoding RNA Malat1 regulates cerebrovascular pathologies in ischemic stroke. J Neurosci2017;
37: 1797–1806.
11.
LiYWeiJYLiuH, et al.
An oxygen-adaptive interaction between SNHG12 and occludin maintains blood-brain barrier integrity. Cell Rep2022;
39: 110656.
12.
LongFQSuQJZhouJX, et al.
LncRNA SNHG12 ameliorates brain microvascular endothelial cell injury by targeting miR-199a. Neural Regen Res2018;
13: 1919–1926.
13.
StinsMFGillesFKimKS.Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol1997;
76: 81–90.
14.
Percie Du SertNHurstVAhluwaliaA, et al.
The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab2020;
40: 1769–1777.
15.
KörbelinJDogbeviaGMichelfelderS, et al.
A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med2016;
8: 609–625.
16.
LongaEZWeinsteinPRCarlsonS, et al.
Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke1989;
20: 84–91.
17.
ZhaoYMaXZhouY, et al.
DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage. Lab Invest2021;
101: 808–823.
18.
ShiYJiangXZhangL, et al.
Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood-brain barrier disruption after ischemic brain injury. Proc Natl Acad Sci U S A2017;
114: E1243–E1252.
19.
BalesKRO’NeillSMPozdnyakovN, et al.
Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity. Brain2016;
139: 563–577.
20.
ImaiTIwataSHirayamaT, et al.
Intracellular Fe(2+) accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage. Sci Rep2019;
9: 6228.
KuoTCKungHJShihJW.Signaling in and out: long-noncoding RNAs in tumor hypoxia. J Biomed Sci2020;
27: 59.
23.
WangXZhaoDXieH, et al.
Interplay of long non-coding RNAs and HIF-1α: a new dimension to understanding hypoxia-regulated tumor growth and metastasis. Cancer Lett2021;
499: 49–59.
24.
PierceJBFeinbergMW.Long noncoding RNAs in atherosclerosis and vascular injury: pathobiology, biomarkers, and targets for therapy. Arterioscler Thromb Vasc Biol2020;
40: 2002–2017.
25.
FasoloFDi GregoliKMaegdefesselL, et al.
Non-coding RNAs in cardiovascular cell biology and atherosclerosis. Cardiovasc Res2019;
115: 1732–1756.
26.
YaoXYaoRHuangF, et al.
LncRNA SNHG12 as a potent autophagy inducer exerts neuroprotective effects against cerebral ischemia/reperfusion injury. Biochem Biophys Res Commun2019;
514: 490–496.
27.
BaoXWuHZhuX, et al.
The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res2015;
25: 80–92.
28.
HuarteMGuttmanMFeldserD, et al.
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell2010;
142: 409–419.
29.
CastellanoJJMarradesRMMolinsL, et al.
Extracellular vesicle lincRNA-p21 expression in tumor-draining pulmonary vein defines prognosis in NSCLC and modulates endothelial cell behavior. Cancers (Basel)2020;
12: 734.
30.
ChangLLiuTChaiZ, et al.
lincRNA-p21 mediates the anti-Cancer effect of ginkgo biloba extract EGb 761 by stabilizing E-cadherin protein in Colon cancer. Med Sci Monit2018;
24: 9488–9496.
31.
LiCLinLZhangL, et al.
Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway. Pharmacol Res2021;
173: 105920.
32.
WangHHeFLiangB, et al.
p53-Dependent LincRNA-p21 protects against proliferation and anti-apoptosis of vascular smooth muscle cells in atherosclerosis by upregulating SIRT7 via MicroRNA-17-5p. J Cardiovasc Transl Res2021;
14: 426–440.
33.
WangHHeFLiangB, et al.
LincRNA-p21 alleviates atherosclerosis progression through regulating the miR-221/SIRT1/Pcsk9 axis. J Cell Mol Med2021;
25: 9141–9153.
34.
HeCDingJWLiS, et al.
The role of long intergenic noncoding RNA p21 in vascular endothelial cells. DNA Cell Biol2015;
34: 677–683.
35.
CaiJCulleyMKZhaoY, et al.
The role of ubiquitination and deubiquitination in the regulation of cell junctions. Protein Cell2018;
9: 754–769.
36.
ZhangGSTianYHuangJY, et al.
The γ-secretase blocker DAPT reduces the permeability of the blood-brain barrier by decreasing the ubiquitination and degradation of occludin during permanent brain ischemia. CNS Neurosci Ther2013;
19: 53–60.
37.
GuoHIngoliaNTWeissmanJS, et al.
Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature2010;
466: 835–840.
38.
LiJZhaoYChoiJ, et al.
Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice. PLoS Biol2020;
18: e3000734.
39.
TingKKZhaoYShenW, et al.
Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models. Diabetologia2019;
62: 322–334.
40.
KangLJinSWangJ, et al.
AAV vectors applied to the treatment of CNS disorders: clinical status and challenges. J Control Release2023;
355: 458–473.
41.
SundaramSMArrulo PereiraAMüller-FielitzH, et al.
Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency. Brain2022;
145: 4264–4274.
42.
KoepJLBondBBarkerAR, et al.
Sex modifies the relationship between age and neurovascular coupling in healthy adults. J Cereb Blood Flow Metab2023;
43: 1254–1266.
43.
RebchukADHillMDGoyalM, et al.
Exploring sex differences for acute ischemic stroke clinical, imaging and thrombus characteristics in the INTERRSeCT study. J Cereb Blood Flow Metab2023;
43: 1803–1809.
44.
AppelrosPStegmayrBTeréntA.Sex differences in stroke epidemiology: a systematic review. Stroke2009;
40: 1082–1090.
45.
PhanHTBlizzardCLReevesMJ, et al.
Sex differences in Long-Term mortality after stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): a meta-analysis of individual participant data. Circ Cardiovasc Qual Outcomes2017;
10: e003436.
46.
SeaksCEWeekmanEMSudduthTL, et al.
Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling. J Cereb Blood Flow Metab2022;
42: 771–787.
47.
JiaCLovinsCMaloneHM, et al.
Female-specific neuroprotection after ischemic stroke by vitronectin-focal adhesion kinase inhibition. J Cereb Blood Flow Metab2022;
42: 1961–1974.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
